相关实验视频

Updated: Jul 26, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

根据泛癌分析,B4GALNT1通过调节肝细胞癌中的上皮细胞-介质细胞过渡来促进癌变

Wenli Liu^1,2, Yutong Chen³, Jinqiang Yang⁴

¹Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.

The journal of gene medicine

|June 20, 2023

概括

乙-1,4-N-乙烯基银氨基基转移酶1 (B4GALNT1) 通过调节上皮细胞-介质细胞转换 (EMT) 途径促进肝细胞癌 (HCC). 较低的B4GALNT1表达与更好的患者存活率相关,这表明它是肝癌的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症基因组学癌症基因组学

背景情况:

β-1,4-N-乙烯基银胺基转移酶1 (B4GALNT1) 涉及到瘤进展和转移.
它在免疫微环境中的肝细胞癌 (HCC) 中的特定作用需要进一步研究.

研究的目的:

研究B4GALNT1在肝细胞癌 (HCC) 中的致癌作用.
分析B4GALNT1表达和HCC中的瘤免疫微环境之间的相关性.

主要方法:

使用的公共数据库 (TCGA,GTEx,cBioportal) 和生物信息工具 (ImmuCellAI,Timer2).
进行了生存分析,丰富分析 (KEGG,GO),西斑,免疫组织化学和基于细胞的测定 (CCK-8,入侵,迁移).

主要成果:

B4GALNT1在HCC中过度表达,并作为一个独立的预后因素,表达率较低与更好的生存率有关.
在HCC中,B4GALNT1的表达与表皮细胞-介质细胞过渡 (EMT) 途径和免疫激活基因具有积极的相关性.
抑制B4GALNT1抑制了HCC细胞的增殖和入侵,影响了与亡相关的和EMT相关的蛋白质表达.

结论:

B4GALNT1促进HCC的发展,可能通过调节EMT通路.
B4GALNT1代表了一个潜在的预测生物标志物和HCC的治疗目标.

关键词:

B4GALNT1 的意思是在EMT中,EMT是EMT.在HCC中,HCC是HCC,HCC是HCC.免疫透免疫透是什么?瘤环境瘤环境

更多相关视频

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

Induction and Analysis of Epithelial to Mesenchymal Transition

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...